Internationally, Bimeda® has been a leader in production of quality pharmaceuticals for over 30 years. The company manufactures injectable antibacterials, intermamammaries, antibiotics for oral use, powders, tablets/boluses, anthelmintics, vitamin and nutritional supplements.   Cross Vetpharm operates six manufacturing plants in Ireland, the United Kingdom, Canada and the United States. Each facility conforms to the highest standards of international regulating agencies. The company's commitment to leading edge technology and quality production is evident in the Dublin, Ireland facility, the first sterile penicillin-based intra-mammary plant in the world. The company also produces sterile penicillin-based injectables and recently commissioned a new facility for manufacturing EPA registered ectoparasiticides.		Bimeda® operates three pharmaceutical plants in North America for production of Bimeda® and Osborn-labeled products. Sterile injectables, liquids and pastes are produced in Cambridge, Canada. The Le Sueur, Minnesota plant manufactures powders, tablets and boluses. Injectable penicillin products are manufactured in Irwindale, California.   The same high standards that go into the manufacture of Bimeda® and Osborn products are available to other, select animal health suppliers. Many national and multi-national companies have found Bimeda® to be an excellent source for private-label and contract manufactured out-source needs.